Neuren Pharmaceuticals
NEU.AX
#5549
Rank
C$1.42 B
Marketcap
$10.93
Share price
-3.19%
Change (1 day)
-45.92%
Change (1 year)

Operating Margin for Neuren Pharmaceuticals (NEU.AX)

Operating Margin at the end of 2023: 88.45%

According to Neuren Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 88.45%. At the end of 2023 the company had an Operating Margin of 88.45%.

Operating Margin history for Neuren Pharmaceuticals from 2002 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202388.45%6895.8%
20221.26%
201822.69%
2010-107.37%20010.14%
2009-0.53%-99.92%
2008-675.29%-47.54%
2007-1,287.13%-77.99%
2006-5,848.45%203.1%
2005-1,929.57%413.9%
2004-375.47%88.55%
2003-199.14%-22.6%
2002-257.29%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.